Emergent Biosolutions Inc.’s (EBS) MACD indicator has moved into bearish territory with a reading of –0.1555. The Zacks Rank # 5 (“Strong Sell”) stock decreased more than 1.48% to $15.28 in morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending December 2012 has decreased by 2 cents over the past two months to 66 cents per share.
EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report
More From Zacks.com
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
These proven wealth builders could be exactly what you're searching for right now.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
Here's what could happen next to Microsoft shares.
It's been an "everything buy bonds" bull rally in markets for months, but BofA is cautiously watching a couple of indicators.
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
It's possible to construct a winning long-term investment strategy with just low-cost index funds.
The good news for retirement savers using 401(k) plans and similar workplace retirement accounts is that the improving stock market is raising account balances. The average 401(k) is up by an average of $7,250 – a gain of 9.6% – since the end of 2022, according to a Bank of America report. The report also […] The post Here’s How Much Americans’ 401(k) Balances Have Grown in 2023. Is Yours Keeping Pace? appeared first on SmartReads by SmartAsset.